| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.95e-20 | 114 | 290 | 23 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.70e-19 | 124 | 290 | 23 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.85e-18 | 137 | 290 | 23 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP9X CTSC USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 TRHDE USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.97e-17 | 192 | 290 | 25 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 LVRN USP17L21 USP17L1 USP17L20 USP9X CTSC PSMB9 USP17L19 USP17L18 LONP1 USP17L17 TPP1 USP17L3 C1R KEL USP47 USP17L13 TRHDE USP17L4 USP17L2 USP17L12 PRSS41 USP28 USP17L11 USP17L24 USP17L5 USP17L10 XPNPEP2 USP17L6P USP17L22 USP17L15 USP17L8 | 5.27e-10 | 654 | 290 | 33 | GO:0008233 |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 2.15e-07 | 5 | 290 | 4 | GO:0035731 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.47e-06 | 7 | 290 | 4 | GO:0004769 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.02e-04 | 7 | 290 | 3 | GO:0035005 | |
| GeneOntologyMolecularFunction | glutathione binding | 1.14e-04 | 18 | 290 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 1.42e-04 | 19 | 290 | 4 | GO:0016863 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.76e-04 | 20 | 290 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 2.10e-04 | 2 | 290 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO9B MYO10 PSMC5 MCM3 LONP1 ABCC8 HELZ ATP11C ASCC3 DNAH8 DNAH9 ABCC10 SLC27A2 ABCC9 MSH2 CHD7 MSH4 ABCA5 ATP12A ATP1B1 DNAH11 | 2.69e-04 | 614 | 290 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 4.59e-04 | 11 | 290 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.96e-04 | 69 | 290 | 6 | GO:0005504 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 5.06e-04 | 26 | 290 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 6.05e-04 | 12 | 290 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 6.25e-04 | 3 | 290 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | ADP binding | 6.41e-04 | 48 | 290 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 6.78e-04 | 28 | 290 | 4 | GO:0004602 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 6.78e-04 | 28 | 290 | 4 | GO:0005242 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.78e-04 | 28 | 290 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO9B PSMC5 MCM3 LONP1 ABCC8 ATP11C ASCC3 DNAH8 DNAH9 ABCC10 ABCC9 MSH2 CHD7 ABCA5 ATP12A DNAH11 | 7.71e-04 | 441 | 290 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | glutathione transferase activity | 7.77e-04 | 29 | 290 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 9.59e-04 | 107 | 290 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.21e-03 | 15 | 290 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 1.21e-03 | 15 | 290 | 3 | GO:0004559 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 1.24e-03 | 4 | 290 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.24e-03 | 4 | 290 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.24e-03 | 4 | 290 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.43e-03 | 34 | 290 | 4 | GO:0008266 | |
| GeneOntologyMolecularFunction | mannosidase activity | 1.48e-03 | 16 | 290 | 3 | GO:0015923 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 2.05e-03 | 122 | 290 | 7 | GO:0072341 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.10e-03 | 18 | 290 | 3 | GO:0008569 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.34e-20 | 125 | 291 | 24 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.39e-19 | 144 | 291 | 24 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L1 USP17L20 USP9X TRIM49C LRRK2 USP17L19 MEFV MAP3K1 USP17L18 ABRAXAS2 FBXO6 USP17L17 UBE3A KLHL13 USP17L3 FGFR3 USP47 USP17L13 MGRN1 TRIM49 USP17L4 USP17L2 DET1 TRIM51 USP17L12 USP28 USP17L11 USP17L24 USP17L5 UFL1 USP17L10 SIRT7 GMCL2 DZIP3 USP17L6P USP17L22 TRIM49B USP17L15 USP17L8 | 1.07e-09 | 1009 | 291 | 41 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L1 USP17L20 USP9X TRIM49C LRRK2 USP17L19 MEFV MAP3K1 USP17L18 ABRAXAS2 FBXO6 USP17L17 UBE3A KLHL13 USP17L3 FGFR3 USP47 USP17L13 MGRN1 TRIM49 USP17L4 USP17L2 DET1 TRIM51 USP17L12 USP28 USP17L11 USP17L24 USP17L5 UFL1 USP17L10 SIRT7 GMCL2 DZIP3 USP17L6P USP17L22 TRIM49B USP17L15 USP17L8 | 6.47e-09 | 1074 | 291 | 41 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 2.60e-06 | 8 | 291 | 4 | GO:0071947 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.47e-05 | 14 | 291 | 4 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.18e-05 | 16 | 291 | 4 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 6.18e-05 | 16 | 291 | 4 | GO:1900153 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 7.91e-05 | 51 | 291 | 6 | GO:1990573 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.58e-04 | 179 | 298 | 10 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.58e-04 | 179 | 298 | 10 | GO:0030672 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | PSMC5 MCM3 DAPK1 KAT2A TRRAP PIK3C2B PIK3CA PIK3CD STRADA POLE POLR3C CCNB2 PYCARD PRKAG1 | 3.47e-04 | 335 | 298 | 14 | GO:0061695 |
| GeneOntologyCellularComponent | outer dynein arm | 5.74e-04 | 12 | 298 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 5.90e-04 | 48 | 298 | 5 | GO:0030119 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 6.02e-04 | 3 | 298 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L1 USP17L20 LRRK2 USP17L19 NSDHL USP17L18 MEST DST USP17L17 PGAP1 USP17L3 ATP11C SLC27A2 USP17L13 SEL1L BICD2 ATG9B USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 GRIA1 UFL1 USP17L10 XPO1 ALG2 CPTP USP17L6P USP17L22 USP17L15 USP17L8 | 6.78e-04 | 1327 | 298 | 34 | GO:0042175 |
| GeneOntologyCellularComponent | coated membrane | 8.16e-04 | 106 | 298 | 7 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 8.16e-04 | 106 | 298 | 7 | GO:0030117 | |
| HumanPheno | Abnormal social development | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB ABCC8 C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 ALG2 AP4S1 PIEZO2 VANGL1 AP3B2 SPEN | 1.58e-05 | 908 | 102 | 36 | HP:0025732 |
| HumanPheno | Disinhibition | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 PIEZO2 VANGL1 AP3B2 SPEN | 2.23e-05 | 807 | 102 | 33 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 PIEZO2 VANGL1 AP3B2 SPEN | 2.23e-05 | 807 | 102 | 33 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 PIEZO2 VANGL1 AP3B2 SPEN | 2.23e-05 | 807 | 102 | 33 | HP:5200123 |
| HumanPheno | Social disinhibition | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 PIEZO2 VANGL1 AP3B2 SPEN | 2.23e-05 | 807 | 102 | 33 | HP:5200029 |
| HumanPheno | Abnormal joint physiology | ATR USP9X NCF1 GDF6 PSMB9 LMBRD2 NEB CASZ1 MEFV TWIST1 RUSC2 NSDHL LONP1 NF1 DST AP1G1 UBE3A PIK3CA STRADA ABCC8 C19orf12 C1R FGFR3 GOLGA2 BICD2 SIN3B POLE CEP290 CHSY1 TWIST2 ABCC9 SPG11 MSH2 CHD7 ALG2 CEP55 WDR19 AP4S1 PIEZO2 PPT1 WDR11 VANGL1 HS2ST1 SPEN CNOT1 SOS1 | 3.96e-05 | 1358 | 102 | 46 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | ATR USP9X NCF1 GDF6 PSMB9 LMBRD2 NEB CASZ1 MEFV TWIST1 RUSC2 NSDHL LONP1 NF1 DST AP1G1 UBE3A PIK3CA STRADA ABCC8 C19orf12 C1R FGFR3 GOLGA2 BICD2 SIN3B POLE CEP290 CHSY1 TWIST2 ABCC9 SPG11 MSH2 CHD7 ALG2 CEP55 WDR19 AP4S1 PIEZO2 PPT1 WDR11 VANGL1 HS2ST1 SPEN CNOT1 SOS1 | 3.96e-05 | 1358 | 102 | 46 | HP:0011729 |
| HumanPheno | Abnormally increased volition | MAOA ATR USP9X NCF1 LRRK2 CASZ1 TNFSF4 RUSC2 NSDHL SLITRK2 NF1 AP1G1 UBE3A PIK3CA NFIB ABCC8 C19orf12 PGAP1 SCN3A CLTC ASPM FGFR3 ASCC3 NDST1 RBL2 POLE CEP290 GRIA1 MSH2 CHD7 PIEZO2 VANGL1 AP3B2 SPEN | 4.09e-05 | 869 | 102 | 34 | HP:5200263 |
| HumanPheno | Epicanthus | DIS3L2 NCF1 TRRAP CASZ1 TWIST1 NSDHL LONP1 NF1 FOXL2 AP1G1 UBE3A PIK3CA ASPM FGFR3 NDST1 TWIST2 ABCC9 CHD7 AP3B1 ALG2 WDR19 PIEZO2 ABCA5 HS2ST1 SPEN CNOT1 SOS1 | 4.60e-05 | 614 | 102 | 27 | HP:0000286 |
| HumanPheno | Joint laxity | 9.68e-05 | 55 | 102 | 7 | HP:0001388 | |
| MousePheno | abnormal cilium morphology | SPEF2 CFAP65 LRGUK AP1G1 CC2D2A CFAP70 DNAH8 DNAH9 GOLGA2 FOXI1 SELENOP DPY19L2 GOPC ARMC12 CEP290 CHD7 CEP55 WDR19 GMCL2 WDR11 SUN3 DNAH11 | 1.68e-06 | 433 | 223 | 22 | MP:0013202 |
| MousePheno | abnormal motile cilium morphology | SPEF2 CFAP65 LRGUK AP1G1 CC2D2A CFAP70 DNAH8 DNAH9 GOLGA2 FOXI1 SELENOP DPY19L2 GOPC ARMC12 CEP55 GMCL2 SUN3 DNAH11 | 2.75e-05 | 370 | 223 | 18 | MP:0013206 |
| MousePheno | abnormal glial cell morphology | ATR SPEF2 LRRK2 PLXNB2 MAP3K1 PTPN13 DST NFIB ASPM MGRN1 NDST1 LAMA4 CHSY1 SPG11 CHD7 OGG1 PPT1 | 3.93e-05 | 345 | 223 | 17 | MP:0003634 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 4.24e-24 | 16 | 291 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 4.24e-24 | 16 | 291 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 1.46e-21 | 71 | 291 | 21 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 1.46e-21 | 71 | 291 | 21 | PS00973 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.03e-21 | 72 | 291 | 21 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.03e-21 | 72 | 291 | 21 | IPR001394 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.03e-21 | 72 | 291 | 21 | PS50235 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 7.88e-21 | 66 | 291 | 20 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.97e-20 | 70 | 291 | 20 | PS00972 |
| Domain | ARM-type_fold | ATR USP9X LRRK2 CTIF TEX10 TRRAP MAP3K1 NF1 AP2A2 AP1G1 PIK3C2B PIK3CA PIK3CD ANKAR CLTC ASPM UTP20 ARMH3 ARMC12 XPO1 AP3B1 AP3B2 | 1.91e-08 | 339 | 291 | 22 | IPR016024 |
| Domain | GST_alpha | 2.85e-07 | 5 | 291 | 4 | IPR003080 | |
| Domain | - | ATR USP9X LRRK2 TEX10 TRRAP NF1 AP2A2 AP1G1 ANKAR ASPM UTP20 ARMC12 XPO1 AP3B1 AP3B2 | 2.22e-06 | 222 | 291 | 15 | 1.25.10.10 |
| Domain | PI3Kc | 3.37e-06 | 16 | 291 | 5 | SM00146 | |
| Domain | - | 3.37e-06 | 16 | 291 | 5 | 1.10.1070.11 | |
| Domain | PI3/4_kinase_cat_dom | 6.44e-06 | 18 | 291 | 5 | IPR000403 | |
| Domain | PI3_PI4_kinase | 6.44e-06 | 18 | 291 | 5 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.44e-06 | 18 | 291 | 5 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.44e-06 | 18 | 291 | 5 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 6.44e-06 | 18 | 291 | 5 | PS50290 | |
| Domain | AAA+_ATPase | PSMC5 MCM3 LONP1 ABCC8 ASCC3 DNAH8 DNAH9 ABCC10 ABCC9 ABCA5 DNAH11 | 1.62e-05 | 144 | 291 | 11 | IPR003593 |
| Domain | AAA | PSMC5 MCM3 LONP1 ABCC8 ASCC3 DNAH8 DNAH9 ABCC10 ABCC9 ABCA5 DNAH11 | 1.62e-05 | 144 | 291 | 11 | SM00382 |
| Domain | ARM-like | ATR USP9X LRRK2 TEX10 TRRAP NF1 AP2A2 AP1G1 ANKAR ASPM UTP20 ARMC12 XPO1 AP3B1 AP3B2 | 2.35e-05 | 270 | 291 | 15 | IPR011989 |
| Domain | PolyA | 3.66e-05 | 5 | 291 | 3 | SM00517 | |
| Domain | PABP | 3.66e-05 | 5 | 291 | 3 | PF00658 | |
| Domain | PABC | 3.66e-05 | 5 | 291 | 3 | PS51309 | |
| Domain | - | 3.66e-05 | 5 | 291 | 3 | 1.10.1900.10 | |
| Domain | PABP_1234 | 3.66e-05 | 5 | 291 | 3 | IPR006515 | |
| Domain | PABP_HYD | 3.66e-05 | 5 | 291 | 3 | IPR002004 | |
| Domain | Adaptin_N | 6.88e-05 | 15 | 291 | 4 | PF01602 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.88e-05 | 15 | 291 | 4 | IPR002553 | |
| Domain | PI3/4_kinase_CS | 6.88e-05 | 15 | 291 | 4 | IPR018936 | |
| Domain | PI3K_rbd | 1.25e-04 | 7 | 291 | 3 | SM00144 | |
| Domain | PI3K_rbd | 1.25e-04 | 7 | 291 | 3 | PF00794 | |
| Domain | PI3K_Ras-bd_dom | 1.25e-04 | 7 | 291 | 3 | IPR000341 | |
| Domain | PI3K_RBD | 1.25e-04 | 7 | 291 | 3 | PS51546 | |
| Domain | P-loop_NTPase | MYO9B MYO10 SPEF2 LRRK2 PSMC5 MCM3 DAPK1 LRGUK LONP1 NOD1 ABCC8 ASPM HELZ ASCC3 DNAH8 DNAH9 ABCC10 NDST1 NDST2 ABCC9 MSH2 CHD7 MSH4 UTP25 ABCA5 HS2ST1 MYO16 DNAH11 | 1.55e-04 | 848 | 291 | 28 | IPR027417 |
| Domain | PI3K_C2 | 1.98e-04 | 8 | 291 | 3 | SM00142 | |
| Domain | PI3K_C2 | 1.98e-04 | 8 | 291 | 3 | PF00792 | |
| Domain | DHC_N1 | 1.98e-04 | 8 | 291 | 3 | PF08385 | |
| Domain | PI3K_C2_dom | 1.98e-04 | 8 | 291 | 3 | IPR002420 | |
| Domain | PI3K_C2 | 1.98e-04 | 8 | 291 | 3 | PS51547 | |
| Domain | Dynein_heavy_dom-1 | 1.98e-04 | 8 | 291 | 3 | IPR013594 | |
| Domain | AP3_beta | 2.42e-04 | 2 | 291 | 2 | IPR026740 | |
| Domain | AP3B_C | 2.42e-04 | 2 | 291 | 2 | IPR029390 | |
| Domain | AP3B1_C | 2.42e-04 | 2 | 291 | 2 | PF14796 | |
| Domain | AP3B1_C | 2.42e-04 | 2 | 291 | 2 | SM01355 | |
| Domain | Sulphorea_rcpt | 2.42e-04 | 2 | 291 | 2 | IPR000388 | |
| Domain | Twist-related | 2.42e-04 | 2 | 291 | 2 | IPR015789 | |
| Domain | PI3Ka | 2.93e-04 | 9 | 291 | 3 | PF00613 | |
| Domain | PI3Ka | 2.93e-04 | 9 | 291 | 3 | SM00145 | |
| Domain | - | 2.93e-04 | 9 | 291 | 3 | 1.25.40.70 | |
| Domain | GST_N | 3.38e-04 | 22 | 291 | 4 | PF02798 | |
| Domain | GST_NTER | 3.38e-04 | 22 | 291 | 4 | PS50404 | |
| Domain | GST_C_3 | 4.14e-04 | 10 | 291 | 3 | PF14497 | |
| Domain | PI_Kinase | 4.14e-04 | 10 | 291 | 3 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 4.14e-04 | 10 | 291 | 3 | IPR001263 | |
| Domain | PIK_HELICAL | 4.14e-04 | 10 | 291 | 3 | PS51545 | |
| Domain | DH_1 | 4.38e-04 | 63 | 291 | 6 | PS00741 | |
| Domain | GST_C | 6.58e-04 | 26 | 291 | 4 | IPR004046 | |
| Domain | GST_C | 6.58e-04 | 26 | 291 | 4 | PF00043 | |
| Domain | RhoGEF | 6.62e-04 | 68 | 291 | 6 | SM00325 | |
| Domain | - | 7.18e-04 | 3 | 291 | 2 | 3.30.420.110 | |
| Domain | PI3K_p85B | 7.18e-04 | 3 | 291 | 2 | SM00143 | |
| Domain | PI3K_p85B | 7.18e-04 | 3 | 291 | 2 | PF02192 | |
| Domain | Coatomer/clathrin_app_Ig-like | 7.42e-04 | 12 | 291 | 3 | IPR013041 | |
| Domain | Glutathione_S-Trfase_N | 7.64e-04 | 27 | 291 | 4 | IPR004045 | |
| Domain | RhoGEF | 7.72e-04 | 70 | 291 | 6 | PF00621 | |
| Domain | DH_2 | 7.72e-04 | 70 | 291 | 6 | PS50010 | |
| Domain | - | 8.33e-04 | 71 | 291 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 8.33e-04 | 71 | 291 | 6 | IPR000219 | |
| Domain | ATPase_dyneun-rel_AAA | 1.20e-03 | 14 | 291 | 3 | IPR011704 | |
| Domain | MT | 1.20e-03 | 14 | 291 | 3 | PF12777 | |
| Domain | AAA_8 | 1.20e-03 | 14 | 291 | 3 | PF12780 | |
| Domain | AAA_5 | 1.20e-03 | 14 | 291 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.20e-03 | 14 | 291 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.20e-03 | 14 | 291 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.20e-03 | 14 | 291 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.20e-03 | 14 | 291 | 3 | PF08393 | |
| Domain | ROC | 1.42e-03 | 4 | 291 | 2 | PS51424 | |
| Domain | Heparan_SO4_deacetylase | 1.42e-03 | 4 | 291 | 2 | IPR021930 | |
| Domain | MutS_II | 1.42e-03 | 4 | 291 | 2 | PF05188 | |
| Domain | PI3K_adapt-bd_dom | 1.42e-03 | 4 | 291 | 2 | IPR003113 | |
| Domain | ROC_dom | 1.42e-03 | 4 | 291 | 2 | IPR020859 | |
| Domain | DNA_mmatch_repair_MutS_con_dom | 1.42e-03 | 4 | 291 | 2 | IPR007860 | |
| Domain | HSNSD | 1.42e-03 | 4 | 291 | 2 | PF12062 | |
| Domain | PI3K_ABD | 1.42e-03 | 4 | 291 | 2 | PS51544 | |
| Domain | DHC_fam | 1.48e-03 | 15 | 291 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.48e-03 | 15 | 291 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.48e-03 | 15 | 291 | 3 | IPR004273 | |
| Domain | - | SPEF2 LRRK2 PSMC5 MCM3 LRGUK LONP1 NOD1 ABCC8 HELZ ASCC3 DNAH8 DNAH9 ABCC10 NDST1 NDST2 ABCC9 MSH2 CHD7 MSH4 UTP25 ABCA5 HS2ST1 DNAH11 | 1.51e-03 | 746 | 291 | 23 | 3.40.50.300 |
| Domain | GST_CTER | 1.85e-03 | 34 | 291 | 4 | PS50405 | |
| Domain | AP_beta | 2.35e-03 | 5 | 291 | 2 | IPR026739 | |
| Domain | MUTSd | 2.35e-03 | 5 | 291 | 2 | SM00533 | |
| Domain | MUTSac | 2.35e-03 | 5 | 291 | 2 | SM00534 | |
| Domain | MutS_IV | 2.35e-03 | 5 | 291 | 2 | PF05190 | |
| Domain | MutS_III | 2.35e-03 | 5 | 291 | 2 | PF05192 | |
| Domain | DNA_mismatch_repair_MutS_C | 2.35e-03 | 5 | 291 | 2 | IPR000432 | |
| Domain | MutS_V | 2.35e-03 | 5 | 291 | 2 | PF00488 | |
| Domain | DNA_mismatch_repair_MutS_clamp | 2.35e-03 | 5 | 291 | 2 | IPR007861 | |
| Domain | DNA_MISMATCH_REPAIR_2 | 2.35e-03 | 5 | 291 | 2 | PS00486 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 ABHD17B USP17L6P USP17L22 USP17L15 USP17L8 | 8.30e-25 | 45 | 222 | 20 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L1 USP17L20 USP9X PSMC5 USP17L19 PSME1 KAT2A TRRAP USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.70e-17 | 191 | 222 | 26 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L1 USP17L20 USP9X PSMC5 USP17L19 PSME1 KAT2A TRRAP USP17L18 ABRAXAS2 NOD1 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.34e-16 | 262 | 222 | 28 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP9X PSMB9 PSMC5 USP17L19 PSME1 KAT2A TRRAP USP17L18 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 1.03e-15 | 221 | 222 | 26 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP9X PSMB9 PSMC5 USP17L19 PSME1 KAT2A TRRAP USP17L18 ABRAXAS2 NOD1 USP17L17 USP17L3 USP47 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 2.76e-14 | 299 | 222 | 28 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L1 USP17L20 PSMC5 USP17L19 PSME1 USP17L18 NF1 USP17L17 PIK3CA USP17L3 FGFR3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 XPO1 ABHD17B USP17L6P USP17L22 USP17L15 USP17L8 SOS1 | 8.76e-13 | 318 | 222 | 27 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 MAN1A1 USP17L1 USP17L20 USP9X CTSC PSMC5 USP17L19 PSME1 KAT2A GCNT4 TRRAP SSPOP USP17L18 ABRAXAS2 NOD1 MAN1A2 FOXL2 FBXL18 FBXO6 USP17L17 KLHL13 PGAP1 USP17L3 ALB NUP160 GOLGA2 USP47 USP17L13 USP17L4 USP17L2 USP17L12 PRSS41 USP28 USP17L11 USP17L5 GRIA1 USP17L10 XPNPEP2 ALG2 USP17L6P USP17L22 SERPIND1 USP17L15 USP17L8 | 8.13e-07 | 1389 | 222 | 46 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 MAN1A1 USP17L1 USP17L20 USP9X CTSC PSMB9 PSMC5 USP17L19 PSME1 KAT2A GCNT4 TRRAP SSPOP USP17L18 ABRAXAS2 NOD1 MAN1A2 FOXL2 FBXL18 FBXO6 USP17L17 KLHL13 PGAP1 USP17L3 ALB NUP160 GOLGA2 USP47 USP17L13 SEL1L USP17L4 USP17L2 USP17L12 PRSS41 USP28 USP17L11 USP17L24 USP17L5 GRIA1 USP17L10 XPNPEP2 ALG2 USP17L22 SERPIND1 USP17L15 USP17L8 | 1.79e-06 | 1475 | 222 | 47 | M19806 |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 4.91e-06 | 17 | 222 | 5 | MM15891 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9B USP9X NCF1 FAM91A1 PTPN13 DST PIK3CA CLTC VAV3 MCF2L GOLGA2 GOPC SLITRK3 PREX2 PLEKHG6 WDR11 VANGL1 PLEKHG3 SPEN NCF1B SOS1 | 6.13e-06 | 439 | 222 | 21 | MM15595 |
| Pathway | REACTOME_HEME_DEGRADATION | 1.18e-05 | 20 | 222 | 5 | MM14721 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 5.63e-05 | 27 | 222 | 5 | MM15693 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9B USP9X NCF1 FAM91A1 PTPN13 DST PIK3CA CLTC VAV3 MCF2L GOPC SLITRK3 PREX2 PLEKHG6 WDR11 VANGL1 PLEKHG3 SPEN SOS1 | 9.36e-05 | 450 | 222 | 19 | M27078 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | MYO9B NCF1 PIK3CA VAV3 MCF2L PREX2 PLEKHG6 VANGL1 PLEKHG3 NCF1B SOS1 | 1.03e-04 | 175 | 222 | 11 | MM15599 |
| Pathway | SA_PTEN_PATHWAY | 1.21e-04 | 17 | 222 | 4 | M12771 | |
| Pathway | KEGG_LYSOSOME | 1.24e-04 | 121 | 222 | 9 | M11266 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.32e-04 | 32 | 222 | 5 | MM14719 | |
| Pathway | PID_E2F_PATHWAY | 1.47e-04 | 73 | 222 | 7 | M40 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.93e-04 | 19 | 222 | 4 | M47809 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYO9B USP9X NCF1 FAM91A1 PTPN13 DST PIK3CA CLTC VAV3 MCF2L NUP160 GOLGA2 GOPC SLITRK3 XPO1 PREX2 PLEKHG6 WDR11 VANGL1 PLEKHG3 SPEN NCF1B SOS1 | 2.38e-04 | 649 | 222 | 23 | MM15690 |
| Pathway | WP_ESTROGEN_METABOLISM | 3.50e-04 | 22 | 222 | 4 | MM15888 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 3.50e-04 | 22 | 222 | 4 | MM1449 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 4.19e-04 | 23 | 222 | 4 | M47806 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 4.37e-04 | 41 | 222 | 5 | M48095 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 4.97e-04 | 24 | 222 | 4 | M47487 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.00e-38 | 21 | 300 | 19 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.09e-37 | 22 | 300 | 19 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.38e-35 | 24 | 300 | 19 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.72e-35 | 25 | 300 | 19 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.11e-34 | 26 | 300 | 19 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.42e-33 | 33 | 300 | 20 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 15780755 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 9806828 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.42e-33 | 34 | 300 | 20 | 21448158 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-33 | 29 | 300 | 19 | 32527007 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.92e-33 | 35 | 300 | 20 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.92e-33 | 35 | 300 | 20 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.77e-32 | 36 | 300 | 20 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.82e-32 | 37 | 300 | 20 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.11e-27 | 50 | 300 | 19 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.24e-15 | 10 | 300 | 8 | 24207026 |
| Pubmed | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.34e-14 | 12 | 300 | 8 | 24695638 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 8.02e-14 | 14 | 300 | 8 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.94e-12 | 19 | 300 | 8 | 28067227 |
| Pubmed | USP17L7 USP17L1 USP17L3 USP47 USP17L4 USP17L2 PRSS41 USP28 ABHD17B USP17L6P USP17L15 USP17L8 | 5.67e-12 | 81 | 300 | 12 | 12838346 | |
| Pubmed | USP9X PABPC4 PSMC5 RPS16 TEX10 TRRAP LONP1 NF1 DST CLTC XRN1 HELZ UTP20 ASCC3 NUP160 USP47 POLE MSH2 CHD7 XPO1 SIRT7 PABPC1 IGF2R GTF3C1 UTP25 SPEN CNOT1 | 2.50e-11 | 653 | 300 | 27 | 22586326 | |
| Pubmed | USP17L7 USP17L21 MAOA USP17L1 USP17L20 OPN3 LRRK2 USP17L19 NSDHL USP17L18 USP17L17 SCN3A USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 XPNPEP2 PREX2 GSTA3 USP17L6P USP17L22 USP17L15 USP17L8 | 5.09e-11 | 674 | 300 | 27 | 37196079 | |
| Pubmed | MAN1A1 ELMOD2 MYO9B USP9X CTSC PSMC5 RPS16 MCM3 LMBRD2 LONP1 MAN1A2 NF1 INTS2 AP1G1 CLTC XRN1 HELZ ASCC3 MGRN1 CEP290 CHSY1 MSH2 XPO1 AP3B1 PABPC1 ALG2 CEP55 IGF2R GTF3C1 ABHD17B PPT1 WDR11 HS2ST1 PRKAG1 CNOT1 | 1.91e-10 | 1168 | 300 | 35 | 19946888 | |
| Pubmed | PABPC4 IST1 FAM91A1 KAT2A TEX10 TRRAP CASZ1 MEST PTPN13 MAN1A2 DST INTS2 AP1G1 NFIB TPP1 XRN1 HELZ UTP20 ASCC3 SEL1L FNDC3B SIN3B MINK1 UFL1 CHD7 SIRT7 AP3B1 SYT7 CEP55 PCF11 UTP25 WDR11 PTCD1 VANGL1 PLEKHG3 SYNGR2 LSM14B ATP1B1 SPEN | 9.08e-10 | 1497 | 300 | 39 | 31527615 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | PDK1 PABPC4 LMBRD2 PTPN13 AP2A2 INTS2 UBE3A G3BP2 UTP20 GCC1 ASCC3 GOLGA2 CCDC93 SLC27A2 SEL1L USP28 CEP290 AP3B1 PABPC1 CEP55 IGF2R PPT1 WDR11 HS2ST1 UQCC1 ATP1B1 | 2.78e-09 | 754 | 300 | 26 | 33060197 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | DIS3L2 ATR MYO9B PDK1 FAM91A1 KAT2A NSDHL AP2A2 NFIB G3BP2 XRN1 ASPM HELZ ASCC3 CHSY1 PABPC1 GTF3C1 WDR11 PABPC3 CNOT1 | 4.81e-09 | 462 | 300 | 20 | 31138677 |
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 12557262 | ||
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 1728405 | ||
| Pubmed | Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice. | 5.43e-09 | 4 | 300 | 4 | 24964013 | |
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 2049074 | ||
| Pubmed | Mouse glutathione S-transferase Ya subunit: gene structure and sequence. | 5.43e-09 | 4 | 300 | 4 | 3652905 | |
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 1526290 | ||
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 16786188 | ||
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 6330685 | ||
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 19029078 | ||
| Pubmed | Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes. | 5.43e-09 | 4 | 300 | 4 | 27198676 | |
| Pubmed | 5.43e-09 | 4 | 300 | 4 | 9606968 | ||
| Pubmed | 5'-flanking sequence of mouse glutathione S-transferase Ya gene. | 5.43e-09 | 4 | 300 | 4 | 2893339 | |
| Pubmed | USP17L7 USP17L1 FAM91A1 USP17L3 USP17L4 ZNF705G ZNF705B USP17L8 | 7.81e-09 | 48 | 300 | 8 | 16421571 | |
| Pubmed | DIS3L2 MYO10 USP9X E2F7 CCDC178 KAT2A TRRAP TWIST1 NSDHL NOD1 NF1 FBXL18 INTS2 UBE3A PIK3CA STRADA CLTC XRN1 ASPM HELZ MAGEB17 SEL1L SIN3B DET1 RBL2 UFL1 SPG11 XPO1 PREX2 PCED1B PRKAG1 UQCC1 CNOT1 SOS1 | 1.80e-08 | 1327 | 300 | 34 | 32694731 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN1A1 ATR CTSC LMBRD2 RRM1 PLXNB2 IGSF10 MEST OLFML2A MAN1A2 NF1 PTPRJ PTPRS MANEAL PGAP1 NID1 UTP20 TIMELESS GOLGA2 MGRN1 SEL1L NDST1 ITGA11 GOPC LAMA4 CHSY1 IGF2R GTF3C1 PPT1 HS2ST1 CHSY3 ATP1B1 | 1.98e-08 | 1201 | 300 | 32 | 35696571 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO9B USP9X PABPC4 PSMC5 MCM3 TEX10 PLXNB2 TRRAP LONP1 NF1 DST KRT77 CLTC UTP20 ALB ASCC3 NUP160 CEP290 UFL1 MSH2 XPO1 PABPC1 IGF2R GTF3C1 VANGL1 PLEKHG3 ATP1B1 SPEN CNOT1 | 2.60e-08 | 1024 | 300 | 29 | 24711643 |
| Pubmed | 2.70e-08 | 5 | 300 | 4 | 12020353 | ||
| Pubmed | 2.70e-08 | 5 | 300 | 4 | 11851347 | ||
| Pubmed | 2.70e-08 | 5 | 300 | 4 | 16243960 | ||
| Pubmed | 2.70e-08 | 5 | 300 | 4 | 9268051 | ||
| Pubmed | Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. | 2.70e-08 | 5 | 300 | 4 | 3417659 | |
| Pubmed | Expression pattern of GSTP1 and GSTA1 in the pathogenesis of asthma. | 2.70e-08 | 5 | 300 | 4 | 23647087 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DIS3L2 MYO9B PSMC5 RPS16 MCM3 RRM1 TEX10 TRRAP LONP1 NF1 DST FBXL18 AP2A2 AP1G1 UBE3A TPP1 A2ML1 CLTC XRN1 ASPM UTP20 ASCC3 NUP160 CCDC93 FNDC3B POLE MSH2 CHD7 XPO1 PABPC1 PLEK2 GTF3C1 WDR11 PLEKHG3 | 2.87e-08 | 1353 | 300 | 34 | 29467282 |
| Pubmed | Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. | 8.03e-08 | 6 | 300 | 4 | 14672804 | |
| Pubmed | 1.26e-07 | 28 | 300 | 6 | 9714600 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYO9B TEX10 TRRAP CASZ1 TWIST1 NSDHL FOXL2 SH3TC1 A2ML1 UTP20 ALB NUP160 USP47 FOXI1 SIN3B GOPC RBL2 USP28 POLE CHSY1 UFL1 GTF3C1 FOXI2 CHSY3 SPEN | 1.43e-07 | 857 | 300 | 25 | 25609649 |
| Pubmed | 1.80e-07 | 48 | 300 | 7 | 8884266 | ||
| Pubmed | 1.86e-07 | 7 | 300 | 4 | 7894162 | ||
| Pubmed | 1.86e-07 | 7 | 300 | 4 | 1427837 | ||
| Pubmed | 1.86e-07 | 7 | 300 | 4 | 8584275 | ||
| Pubmed | 1.87e-07 | 16 | 300 | 5 | 8649810 | ||
| Pubmed | 3.70e-07 | 8 | 300 | 4 | 7774561 | ||
| Pubmed | 3.70e-07 | 8 | 300 | 4 | 16284450 | ||
| Pubmed | 6.35e-07 | 3 | 300 | 3 | 21940797 | ||
| Pubmed | Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. | 6.61e-07 | 9 | 300 | 4 | 1685137 | |
| Pubmed | DCDC1 PABPC4 TRRAP DST HELZ DNAH8 NUP160 RIOK1 PABPC1 PABPC3 ANKRD36 | 7.76e-07 | 187 | 300 | 11 | 26460568 | |
| Pubmed | USP9X NEB CASZ1 NSDHL NF1 UBE3A NFIB G3BP2 C5 MCF2L USP47 POLE CHD7 AP3B1 WDR19 PPT1 APOL6 SPEN CNOT1 DNAH11 | 8.82e-07 | 638 | 300 | 20 | 31182584 | |
| Pubmed | 1.09e-06 | 10 | 300 | 4 | 26238783 | ||
| Pubmed | 1.09e-06 | 10 | 300 | 4 | 1981995 | ||
| Pubmed | 1.09e-06 | 10 | 300 | 4 | 15870285 | ||
| Pubmed | ATR FAM91A1 LMBRD2 RUSC2 DST AP1G1 TPP1 XRN1 HELZ TIMELESS GOLGA2 MGRN1 FNDC3B RIOK1 POLE MINK1 AP3B1 GTF3C1 WDR11 NEMF | 1.17e-06 | 650 | 300 | 20 | 38777146 | |
| Pubmed | 1.71e-06 | 11 | 300 | 4 | 15100242 | ||
| Pubmed | Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. | 1.71e-06 | 11 | 300 | 4 | 21554947 | |
| Pubmed | USP9X PSMC5 FAM91A1 PSME1 TEX10 ABRAXAS2 LONP1 PTPN13 STYX PTPRJ PTPRS CLTC HELZ GOPC MINK1 CEP290 MSH2 XPO1 AP3B1 CEP55 PCF11 IGF2R WDR11 CCNB2 VANGL1 CNOT1 | 1.73e-06 | 1049 | 300 | 26 | 27880917 | |
| Pubmed | USP9X PTPN13 AP2A2 PIK3C2B XRN1 ASCC3 E2F3 CEP55 CCNB2 CNOT1 | 2.34e-06 | 169 | 300 | 10 | 31462741 | |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 2.53e-06 | 4 | 300 | 3 | 22984479 | |
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 8307579 | ||
| Pubmed | A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. | 2.53e-06 | 4 | 300 | 3 | 8798681 | |
| Pubmed | 2.54e-06 | 12 | 300 | 4 | 12460940 | ||
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 2.54e-06 | 12 | 300 | 4 | 8297798 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR USP9X PABPC4 PSMC5 RPS16 MCM3 NSDHL LONP1 NF1 AP2A2 AP1G1 G3BP2 CLTC CC2D2A ANP32E UTP20 NUP160 RIOK1 POLE DUOX2 UFL1 MSH2 XPO1 AP3B1 SYAP1 PABPC1 IGF2R GTF3C1 NEMF SPEN CNOT1 | 2.59e-06 | 1425 | 300 | 31 | 30948266 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | TRRAP DST UBE3A XRN1 HELZ ALB PIPSL NUP160 USP47 NEMF PRKAG1 | 2.64e-06 | 212 | 300 | 11 | 33853758 |
| Pubmed | 3.65e-06 | 13 | 300 | 4 | 9441664 | ||
| Pubmed | 3.65e-06 | 13 | 300 | 4 | 36421460 | ||
| Pubmed | 3.65e-06 | 13 | 300 | 4 | 2572508 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | USP9X PSMC5 FAM91A1 MCM3 PLXNB2 PTPN13 NF1 PTPRS NID1 ATP11C GTF3C1 WDR11 SPEN | 3.89e-06 | 313 | 300 | 13 | 38270169 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PSMC5 RPS16 MCM3 TRRAP NSDHL AP1G1 UBE3A G3BP2 CLTC ANP32E UTP20 TIMELESS ASCC3 DNAH8 NUP160 POLE MSH2 AP3B1 GTF3C1 CNOT1 | 3.90e-06 | 704 | 300 | 20 | 29955894 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9B USP9X NCF1 E2F7 MCM3 PIK3C2B CLTC ASPM ANP32E HELZ GOLGA2 BICD2 USP28 E2F3 CHD7 POLR3C CCNB2 SPEN | 4.34e-06 | 588 | 300 | 18 | 38580884 |
| Pubmed | PABPC4 LRRK2 RPS16 FAM91A1 MCM3 PTPN13 DST CLTC XRN1 GCC1 ALB NUP160 GOPC MINK1 AP3B1 PCF11 LRIG3 IGF2R WDR11 VANGL1 SPEN | 4.81e-06 | 777 | 300 | 21 | 35844135 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATR TEX10 TRRAP MAP3K1 NF1 DST AP2A2 INTS2 STRADA VAV3 FGFR3 GOLGA2 GOPC RBL2 MINK1 CEP55 GTF3C1 UTP25 CCNB2 PRKAG1 AKAP11 ANKRD36 SOS1 | 5.09e-06 | 910 | 300 | 23 | 36736316 |
| Interaction | SIRT7 interactions | ATR USP9X PABPC4 PSMC5 RPS16 TEX10 TRRAP LONP1 NF1 DST CLTC XRN1 HELZ UTP20 ASCC3 NUP160 USP47 USP17L2 POLE MSH2 CHD7 XPO1 SIRT7 PABPC1 IGF2R GTF3C1 UTP25 SPEN CNOT1 | 9.30e-07 | 744 | 286 | 29 | int:SIRT7 |
| Interaction | FASN interactions | DIS3L2 USP9X NCF1 E2F7 PSME1 TRRAP TWIST1 NSDHL NF1 FBXO6 INTS2 PIK3C2B PIK3CA STRADA XRN1 ASPM HELZ ARMH3 SLC27A2 FOXI1 SEL1L SIN3B ATG9B RIOK1 DET1 UFL1 SPG11 XPO1 SIRT7 PABPC1 PCED1B PPT1 PRKAG1 FOXI2 CNOT1 | 3.16e-06 | 1062 | 286 | 35 | int:FASN |
| Interaction | GSTA2 interactions | 7.80e-06 | 10 | 286 | 4 | int:GSTA2 | |
| Interaction | PCDHGA7 interactions | 2.34e-05 | 25 | 286 | 5 | int:PCDHGA7 | |
| Interaction | CCDC8 interactions | MYO9B USP9X PABPC4 MCM3 PLXNB2 NF1 DST KRT77 CLTC UTP20 ALB ASCC3 GOPC CEP290 UFL1 MSH2 XPO1 PABPC1 IGF2R GTF3C1 VANGL1 PLEKHG3 ATP1B1 CNOT1 | 2.38e-05 | 656 | 286 | 24 | int:CCDC8 |
| Interaction | GSTA3 interactions | 2.77e-05 | 5 | 286 | 3 | int:GSTA3 | |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 SH3TC1 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.41e-18 | 79 | 300 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 SH3TC1 USP17L17 FGFR3 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.12e-12 | 222 | 300 | 16 | chr4p16 |
| Cytoband | 8p23.1 | USP17L7 USP17L1 LONRF1 USP17L3 USP17L4 USP17L2 ZNF705D ZNF705G ZNF705B USP17L8 | 8.19e-08 | 154 | 300 | 10 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p12 | 4.50e-07 | 142 | 300 | 9 | chr6p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | USP17L7 USP17L1 LONRF1 USP17L3 USP17L4 USP17L2 ZNF705D ZNF705G ZNF705B USP17L8 FAM87A | 4.84e-07 | 234 | 300 | 11 | chr8p23 |
| Cytoband | 6p12.1 | 2.35e-06 | 33 | 300 | 5 | 6p12.1 | |
| Cytoband | 14q23.3 | 6.43e-04 | 26 | 300 | 3 | 14q23.3 | |
| Cytoband | 5q31 | 9.84e-04 | 115 | 300 | 5 | 5q31 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 6.35e-05 | 8 | 192 | 3 | 831 | |
| GeneFamily | Glutathione S-transferases | 1.31e-04 | 25 | 192 | 4 | 567 | |
| GeneFamily | ATP binding cassette subfamily C | 3.12e-04 | 13 | 192 | 3 | 807 | |
| GeneFamily | Mannosidases alpha class 1 | 6.64e-04 | 4 | 192 | 2 | 1193 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.78e-04 | 66 | 192 | 5 | 722 | |
| GeneFamily | Dyneins, axonemal | 7.18e-04 | 17 | 192 | 3 | 536 | |
| GeneFamily | MutS homologs|PWWP domain containing | 1.10e-03 | 5 | 192 | 2 | 1026 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.64e-03 | 206 | 192 | 8 | 682 | |
| GeneFamily | Ubiquitin specific peptidases | 2.94e-03 | 56 | 192 | 4 | 366 | |
| GeneFamily | E2F transcription factors | 3.01e-03 | 8 | 192 | 2 | 982 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.43e-03 | 95 | 192 | 5 | 59 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.85e-03 | 9 | 192 | 2 | 1234 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 KLHL13 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.59e-21 | 86 | 296 | 20 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.08e-17 | 112 | 296 | 19 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 NSDHL USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.08e-15 | 160 | 296 | 20 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L1 USP17L20 DAPK1 USP17L19 PLXNB2 ACOX2 USP17L18 USP17L17 GSTA5 TPP1 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 RBL2 USP17L11 USP17L5 USP17L10 GSTA1 GSTA2 GSTA3 PLEK2 SIDT2 PLEKHG6 USP17L6P USP17L22 USP17L15 USP17L8 | 1.53e-11 | 647 | 296 | 31 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 MAN1A1 USP17L1 USP17L20 MCM3 DAPK1 CCDC178 USP17L19 ACOX2 USP17L18 FBXO6 USP17L17 UBE3A PTPRS STRADA KLHL13 USP17L3 NID1 USP47 USP17L13 SIN3B ATG9B USP17L4 USP17L2 USP17L12 RBL2 USP17L11 LAMA4 USP17L5 USP17L10 MSH2 PLEK2 LRIG3 TOB1 USP17L6P CTF1 USP17L22 USP17L15 USP17L8 SOS1 | 2.62e-10 | 1198 | 296 | 41 | MM1062 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L1 PDK1 USP17L20 CTSC NCF1 MCM3 USP17L19 MEFV MAP3K1 TNFSF4 USP17L18 PTPRJ USP17L17 USP17L3 USP17L13 ATG9B USP17L4 GPR18 USP17L2 USP17L12 RBL2 USP17L11 MINK1 USP17L5 USP17L10 XPO1 POLR3C UTP25 PPT1 DZIP3 CD53 USP17L6P USP17L22 NCF1B USP17L15 USP17L8 | 4.78e-10 | 1072 | 296 | 38 | MM1031 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L1 USP17L20 PSMB9 DAPK1 USP17L19 PLXNB2 ACOX2 USP17L18 USP17L17 GSTA5 TPP1 C19orf12 USP17L3 GCC1 USP17L13 ATG9B USP17L4 USP17L2 USP17L12 RBL2 USP17L11 ASAH2 USP17L5 USP17L10 SIRT7 GSTA1 GSTA2 GSTA3 PLEK2 AP4S1 SIDT2 PLEKHG6 USP17L6P USP17L22 USP17L15 USP17L8 | 1.84e-08 | 1226 | 296 | 38 | MM979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MAN1A1 ATR MYO9B USP9X SPEF2 PSMB9 RPS16 PSME1 IL18RAP MAN1A2 STYX PTPRJ UBE3A PIK3CD TPP1 G3BP2 C19orf12 XRN1 ANP32E HELZ VAV3 ASCC3 USP47 BICD2 RBL2 NDST2 CHSY1 SPG11 XPO1 OGG1 PCF11 PCED1B PPT1 NEMF DZIP3 CD53 AKAP11 SPEN CNOT1 SOS1 | 3.59e-07 | 1492 | 296 | 40 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ATR MYO10 USP9X JAKMIP2 PTPN13 UBE3A PIK3CA NFIB ASPM NID1 USP47 CEP290 UFL1 SPG11 MSH2 XPO1 AP3B1 CEP55 PIEZO2 ABCA5 WDR11 NEMF AKAP11 ATP1B1 | 5.23e-07 | 656 | 296 | 24 | M18979 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 5.85e-07 | 44 | 296 | 7 | MM485 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATR MYO9B MYO10 USP9X DAPK1 CTIF TRRAP PTPN13 DST UBE3A NFIB HELZ UTP20 ASCC3 NUP160 CCDC93 CHSY1 E2F3 SPG11 MSH2 XPO1 AP3B1 PCF11 IGF2R AKAP11 SPEN SOS1 | 1.76e-06 | 856 | 296 | 27 | M4500 |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 1.35e-05 | 96 | 296 | 8 | M5910 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_DN | 1.86e-05 | 200 | 296 | 11 | M7293 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATR MYO10 USP9X DAPK1 TRRAP DST UBE3A NFIB HELZ ASCC3 CCDC93 CHSY1 E2F3 MSH2 XPO1 SPEN SOS1 | 2.56e-05 | 466 | 296 | 17 | M13522 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.38e-05 | 176 | 296 | 10 | M2981 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 4.37e-05 | 35 | 296 | 5 | M588 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN | MYO10 LMBRD2 ABRAXAS2 XRN1 ASPM CCDC93 GSTA3 CEP55 CCNB2 AP3B2 | 6.74e-05 | 191 | 296 | 10 | M9973 |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 9.09e-05 | 198 | 296 | 10 | M7605 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP | 9.88e-05 | 200 | 296 | 10 | M3957 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | PDK1 MYO10 DAPK1 UBE3A NDST1 SELENOP GPR18 USP28 NIPAL1 ATP1B1 | 9.88e-05 | 200 | 296 | 10 | M9262 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | USP9X JAKMIP2 SLITRK2 SCN3A ATP11C TRHDE PCDHB10 SLCO5A1 ABCA5 CNTNAP4 CHSY3 | 3.69e-06 | 151 | 269 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 1.62e-05 | 64 | 269 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | MAOA MYO10 IGSF10 MEST OLFML2A BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 | 7.82e-10 | 199 | 292 | 13 | 212e89d097753790061310373a1fafba773488b6 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | MAOA MYO10 IGSF10 MEST OLFML2A BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 | 7.82e-10 | 199 | 292 | 13 | 14b676aa289c0578a37be32cec3ea285c79d97cc |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | IGSF10 BMP5 DST PTPRS NFIB C1R NID1 PLEKHH2 LAMA4 GRIA1 TWIST2 PIEZO2 | 7.34e-09 | 196 | 292 | 12 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGSF10 MEST OLFML2A BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.71e-09 | 199 | 292 | 12 | b4a737575be9f8c65771832dd8cd25328d5dae0d |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | IGSF10 MEST OLFML2A BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.71e-09 | 199 | 292 | 12 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | IGSF10 MEST OLFML2A BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.71e-09 | 199 | 292 | 12 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 IGSF10 OLFML2A BMP5 DST PLEKHH2 TRHDE SELENOP LAMA4 PREX2 PIEZO2 | 5.26e-08 | 189 | 292 | 11 | 203c80030df08ae112f9ae4043709f455d87ce89 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 BMP5 DST PTPRS NID1 PLEKHH2 TRHDE LAMA4 GRIA1 PREX2 PIEZO2 | 6.51e-08 | 193 | 292 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 BMP5 DST PTPRS NID1 PLEKHH2 TRHDE LAMA4 GRIA1 PREX2 PIEZO2 | 6.51e-08 | 193 | 292 | 11 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | MYO10 OLFML2A BMP5 DST PTPRS NID1 PLEKHH2 TRHDE LAMA4 GRIA1 PIEZO2 | 6.51e-08 | 193 | 292 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 BMP5 DST PTPRS PGAP1 NID1 PLEKHH2 TRHDE LAMA4 GRIA1 PIEZO2 | 6.86e-08 | 194 | 292 | 11 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | MYO10 BMP5 DST PTPRS NFIB NID1 PLEKHH2 TRHDE LAMA4 GRIA1 PIEZO2 | 7.23e-08 | 195 | 292 | 11 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 7.23e-08 | 195 | 292 | 11 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 7.23e-08 | 195 | 292 | 11 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 7.61e-08 | 196 | 292 | 11 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 7.61e-08 | 196 | 292 | 11 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 7.61e-08 | 196 | 292 | 11 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | MAOA IGSF10 OLFML2A BMP5 DST C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.02e-08 | 197 | 292 | 11 | 156155c2f0c1a2461e45803da578af18ee221660 |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | MAOA IGSF10 OLFML2A BMP5 DST C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.02e-08 | 197 | 292 | 11 | d5d9263451f6c10cb3b9c17740183ca334e24851 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.02e-08 | 197 | 292 | 11 | 13896ec65ccda0b928c91d41112dc01b480036b7 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGSF10 BMP5 DST PTPRS C1R NID1 PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.02e-08 | 197 | 292 | 11 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | SPEF2 PPIL6 NFIB CFAP70 ADGRF1 SLC27A2 GSTA1 GSTA2 ABCA5 ATP1B1 DNAH11 | 8.02e-08 | 197 | 292 | 11 | 272c7f4e582ef57564450540242b0db766b78328 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | MAOA MYO10 DAPK1 IGSF10 BMP5 DST NFIB PLEKHH2 SELENOP GRIA1 PIEZO2 | 8.02e-08 | 197 | 292 | 11 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | IGSF10 BMP5 DST NID1 PLEKHH2 TRHDE SELENOP LAMA4 PREX2 GTF3C1 MYO16 | 9.35e-08 | 200 | 292 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BMP5 DST PTPRS C1R NID1 PLEKHH2 TRHDE LAMA4 GRIA1 TWIST2 PIEZO2 | 9.35e-08 | 200 | 292 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DCDC1 SPEF2 CFAP65 LRGUK CFAP70 DNAH9 SLC27A2 GSTA1 DZIP3 DNAH11 | 2.67e-07 | 176 | 292 | 10 | dee780cfa85234a7cd7bf440b66b84cec959893e |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.67e-07 | 187 | 292 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | DCDC1 SPEF2 PPIL6 CFAP70 DNAH9 SLC27A2 GSTA1 GSTA2 DZIP3 DNAH11 | 6.24e-07 | 193 | 292 | 10 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DCDC1 SPEF2 PPIL6 CFAP65 CC2D2A CFAP70 DNAH9 SLC27A2 DZIP3 DNAH11 | 6.24e-07 | 193 | 292 | 10 | e1b76102f812c433195d1e8811fdd3293a7bc22e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 OLFML2A BMP5 DST PLEKHH2 TRHDE SELENOP LAMA4 GRIA1 PIEZO2 | 6.54e-07 | 194 | 292 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPEF2 PPIL6 CFAP70 ADGRF1 DUOX2 GSTA1 DZIP3 ATP12A PPP1R36 DNAH11 | 6.86e-07 | 195 | 292 | 10 | d211a836cf711fdb91b10d512f09d462be937cc5 |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPS16 IGSF10 AP2A2 PTPRS CLTC NID1 FNDC3B SELENOP SIDT2 IGF2R | 7.18e-07 | 196 | 292 | 10 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPS16 IGSF10 AP2A2 PTPRS CLTC NID1 FNDC3B SELENOP SIDT2 IGF2R | 7.18e-07 | 196 | 292 | 10 | 44f5b1b474399c9316729155f2ea95a82ca66e30 |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | SPEF2 PPIL6 ACOX2 CFAP65 CFAP70 DNAH9 FBXO36 WDR19 PPP1R36 LRRC36 | 7.53e-07 | 197 | 292 | 10 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYO10 IGSF10 BMP5 DST PLEKHH2 TRHDE SELENOP LAMA4 GRIA1 MYO16 | 7.53e-07 | 197 | 292 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | MAOA MYO10 IGSF10 OLFML2A BMP5 DST C1R PLEKHH2 SELENOP GRIA1 | 7.53e-07 | 197 | 292 | 10 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | MYO10 IGSF10 MEST BMP5 DST NFIB PLEKHH2 SELENOP LAMA4 PIEZO2 | 7.53e-07 | 197 | 292 | 10 | 31a1852911bda38543916585fda34255fd62a134 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.88e-07 | 198 | 292 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 TWIST2 PIEZO2 | 7.88e-07 | 198 | 292 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.88e-07 | 198 | 292 | 10 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.88e-07 | 198 | 292 | 10 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.25e-07 | 199 | 292 | 10 | 7f4840ae6a888380feca722543e5e52783f3e35d |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.25e-07 | 199 | 292 | 10 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.25e-07 | 199 | 292 | 10 | fb23ecce41e31e2cc01814e3c0add756f489561f |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYO10 IGSF10 BMP5 DST NID1 PLEKHH2 SELENOP LAMA4 PREX2 MYO16 | 8.25e-07 | 199 | 292 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | FAM91A1 KAT2A MEST ASPM TIMELESS E2F3 XPO1 CEP55 UTP25 CCNB2 | 8.25e-07 | 199 | 292 | 10 | b10698aee2e6c17bc559eb4f723024141f914b90 |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.25e-07 | 199 | 292 | 10 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.25e-07 | 199 | 292 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | FAM91A1 KAT2A MEST ASPM TIMELESS E2F3 XPO1 CEP55 UTP25 CCNB2 | 8.25e-07 | 199 | 292 | 10 | 38f1f612b29feb868322999ceeda78e52447ec4f |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.25e-07 | 199 | 292 | 10 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 8.40e-07 | 154 | 292 | 9 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.64e-07 | 200 | 292 | 10 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.64e-07 | 200 | 292 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.64e-07 | 200 | 292 | 10 | cc6062dac07916c29091fc6bee2b864d29e6525b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.64e-07 | 200 | 292 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.64e-07 | 200 | 292 | 10 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PPIL6 JAKMIP2 CFAP65 A2ML1 ALB ADGRF1 DNAH9 DUOX2 GSTA3 ATP12A | 8.64e-07 | 200 | 292 | 10 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IGSF10 BMP5 DST PTPRS C1R PLEKHH2 SELENOP LAMA4 GRIA1 PIEZO2 | 8.64e-07 | 200 | 292 | 10 | 20112be28f80baffad92641c9cfd7c3718967dbb |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.64e-07 | 200 | 292 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | MYO10 MEST OLFML2A BMP5 DST NFIB PLEKHH2 SELENOP LAMA4 PIEZO2 | 8.64e-07 | 200 | 292 | 10 | 0ed49c2177b58269ff7653db6be7d68633a5d34a |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.64e-07 | 200 | 292 | 10 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PPIL6 JAKMIP2 CFAP65 A2ML1 ALB ADGRF1 DNAH9 DUOX2 GSTA3 ATP12A | 8.64e-07 | 200 | 292 | 10 | da12821e8a0657869ca0f75d351cce2d7605a505 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.64e-07 | 200 | 292 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.64e-07 | 200 | 292 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-06 | 162 | 292 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 169 | 292 | 9 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 177 | 292 | 9 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-06 | 177 | 292 | 9 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.67e-06 | 177 | 292 | 9 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-06 | 177 | 292 | 9 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 178 | 292 | 9 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 178 | 292 | 9 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 2.79e-06 | 178 | 292 | 9 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 178 | 292 | 9 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 180 | 292 | 9 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-06 | 180 | 292 | 9 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-06 | 180 | 292 | 9 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 184 | 292 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 184 | 292 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 184 | 292 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.00e-06 | 186 | 292 | 9 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-06 | 187 | 292 | 9 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.18e-06 | 187 | 292 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.18e-06 | 187 | 292 | 9 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-06 | 187 | 292 | 9 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 4.56e-06 | 189 | 292 | 9 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 189 | 292 | 9 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.56e-06 | 189 | 292 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 190 | 292 | 9 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 190 | 292 | 9 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.76e-06 | 190 | 292 | 9 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-06 | 191 | 292 | 9 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.96e-06 | 191 | 292 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.96e-06 | 191 | 292 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Ciliated-cil-3|World / Class top | SPEF2 CFAP65 LRGUK CFAP70 DNAH9 FBXO36 PPP1R36 LRRC36 DNAH11 | 5.18e-06 | 192 | 292 | 9 | 4989ebb8812b8af1870599acd932849122c05a29 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-06 | 192 | 292 | 9 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 5.18e-06 | 192 | 292 | 9 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.18e-06 | 192 | 292 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.40e-06 | 193 | 292 | 9 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.40e-06 | 193 | 292 | 9 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| Drug | quercetin 3-arabinopyranoside | 3.16e-07 | 6 | 277 | 4 | ctd:C428865 | |
| Drug | 1-cyano-2-hydroxy-3-butene | 3.16e-07 | 6 | 277 | 4 | ctd:C055903 | |
| Drug | isobutyl nitrite | 1.43e-06 | 30 | 277 | 6 | CID000010958 | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | MYO9B RBM48 NFIB TPP1 HPS1 NUP160 FOXI1 SEL1L TUT1 ABHD17B DZIP3 LSM14B | 4.88e-06 | 194 | 277 | 12 | 2295_DN |
| Drug | benzotriazole | 7.06e-06 | 4 | 277 | 3 | ctd:C012771 | |
| Drug | Biliton | 9.66e-06 | 41 | 277 | 6 | CID000002974 | |
| Drug | bromobenzene | MYO9B PSMC5 PSME1 LONP1 GSTA5 ABCC8 C1R ALB SELENOP GSTA2 GSTA3 | 9.89e-06 | 174 | 277 | 11 | ctd:C032036 |
| Drug | ethyl tert-butyl ether | 1.67e-05 | 27 | 277 | 5 | ctd:C098546 | |
| Drug | Benzoxazoles | 1.75e-05 | 5 | 277 | 3 | ctd:D001583 | |
| Drug | Selenium Compounds | 1.75e-05 | 5 | 277 | 3 | ctd:D018036 | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A | ABRAXAS2 PIK3C2B VAV3 MCF2L ZFP30 CEP290 NDST2 ZNF248 PCF11 SIDT2 VANGL1 | 2.26e-05 | 190 | 277 | 11 | 3297_DN |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | NEB NOD1 NF1 PTPRS GOLGA2 SEL1L MINK1 LAMA4 PLEKHG3 APOL6 LSM14B | 3.15e-05 | 197 | 277 | 11 | 6663_DN |
| Drug | o-dinitrobenzene | 3.37e-05 | 31 | 277 | 5 | CID000010707 | |
| Drug | 2-allylphenol | 3.47e-05 | 6 | 277 | 3 | ctd:C099328 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 3.47e-05 | 6 | 277 | 3 | ctd:C028328 | |
| Drug | isomethyleugenol | 3.47e-05 | 6 | 277 | 3 | ctd:C031050 | |
| Drug | sulfobromophthalein | 3.80e-05 | 103 | 277 | 8 | CID000005345 | |
| Drug | Clch2cosg | 5.74e-05 | 18 | 277 | 4 | CID000163913 | |
| Drug | C14791 | 5.74e-05 | 18 | 277 | 4 | CID011954044 | |
| Drug | C14793 | 5.74e-05 | 18 | 277 | 4 | CID011954046 | |
| Drug | C14803 | 5.74e-05 | 18 | 277 | 4 | CID011954054 | |
| Drug | C14805 | 5.74e-05 | 18 | 277 | 4 | CID011954056 | |
| Drug | C14804 | 5.74e-05 | 18 | 277 | 4 | CID011954055 | |
| Drug | C14806 | 5.74e-05 | 18 | 277 | 4 | CID011954057 | |
| Drug | C14848 | 5.74e-05 | 18 | 277 | 4 | CID011954067 | |
| Drug | C14856 | 5.74e-05 | 18 | 277 | 4 | CID011954069 | |
| Drug | C14855 | 5.74e-05 | 18 | 277 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 5.74e-05 | 18 | 277 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 5.74e-05 | 18 | 277 | 4 | CID000188517 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 MSH2 USP17L6P USP17L22 USP17L15 USP17L8 | 1.73e-30 | 46 | 289 | 21 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 CHD7 USP17L6P USP17L22 USP17L15 USP17L8 | 5.49e-26 | 69 | 289 | 21 | DOID:1682 (implicated_via_orthology) |
| Disease | Colorectal Carcinoma | PSMC5 JAKMIP2 NF1 FOXL2 SH3TC1 PIK3CA PTPRS ABCC8 NID1 ATP11C FGFR3 DNAH8 CCDC93 SELENOP POLE MSH2 PREX2 GMCL2 ABCA5 PYCARD | 2.29e-05 | 702 | 289 | 20 | C0009402 |
| Disease | colorectal cancer (is_implicated_in) | 2.66e-05 | 121 | 289 | 8 | DOID:9256 (is_implicated_in) | |
| Disease | waist-hip ratio | MAN1A1 DIS3L2 MYO9B TEX10 MEFV CFAP65 OLFML2A PIK3C2B PTPRS ABCC8 C19orf12 KCNJ15 XRN1 NID1 PIPSL ABCC10 BICD2 FNDC3B NDST1 ITGA11 RBL2 LAMA4 TWIST2 AP3B1 WDR11 UQCC1 LRRC36 | 8.19e-05 | 1226 | 289 | 27 | EFO_0004343 |
| Disease | Saethre-Chotzen syndrome (implicated_via_orthology) | 9.56e-05 | 2 | 289 | 2 | DOID:14768 (implicated_via_orthology) | |
| Disease | Seborrheic keratosis | 9.56e-05 | 2 | 289 | 2 | C0022603 | |
| Disease | azoospermia (implicated_via_orthology) | 1.32e-04 | 27 | 289 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | ATR CASZ1 MAP3K1 PIK3CA PIK3CD TPP1 VAV3 SELENOP USP28 NDST2 CHD7 XPO1 OGG1 GSTA1 PLEK2 IGF2R SPEN | 1.38e-04 | 616 | 289 | 17 | C0376358 |
| Disease | Prostatic Neoplasms | ATR CASZ1 MAP3K1 PIK3CA PIK3CD TPP1 VAV3 SELENOP USP28 NDST2 CHD7 XPO1 OGG1 GSTA1 PLEK2 IGF2R SPEN | 1.38e-04 | 616 | 289 | 17 | C0033578 |
| Disease | Saethre-Chotzen Syndrome | 2.85e-04 | 3 | 289 | 2 | C0175699 | |
| Disease | Epilepsies, Partial | 2.85e-04 | 3 | 289 | 2 | C0014547 | |
| Disease | cancer (implicated_via_orthology) | 3.38e-04 | 268 | 289 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 3.88e-04 | 15 | 289 | 3 | C0265215 | |
| Disease | Colorectal Neoplasms | FOXL2 SH3TC1 PIK3CA ABCC8 FGFR3 SELENOP POLE MSH2 ABCA5 PYCARD | 4.38e-04 | 277 | 289 | 10 | C0009404 |
| Disease | colorectal carcinoma (is_marker_for) | 4.61e-04 | 37 | 289 | 4 | DOID:0080199 (is_marker_for) | |
| Disease | Weight Gain | 5.14e-04 | 102 | 289 | 6 | C0043094 | |
| Disease | prostate carcinoma | MYO9B CCDC178 MAP3K1 CNTN6 LONP1 PIK3C2B UBE3A NFIB PLEKHH2 USP28 ANXA13 CHSY1 CHD7 WDR11 UQCC1 ANKRD36 SPEN MYO16 DNAH11 SOS1 | 5.48e-04 | 891 | 289 | 20 | EFO_0001663 |
| Disease | Epidermal nevus | 5.66e-04 | 4 | 289 | 2 | cv:C0334082 | |
| Disease | Plagiocephaly | 5.66e-04 | 4 | 289 | 2 | C0265529 | |
| Disease | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | 5.66e-04 | 4 | 289 | 2 | EFO_0020976, EFO_1001930, MONDO_0007915 | |
| Disease | epidermal nevus (is_implicated_in) | 5.66e-04 | 4 | 289 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | TWIST1-related craniosynostosis | 5.66e-04 | 4 | 289 | 2 | cv:C4551902 | |
| Disease | NEVUS, EPIDERMAL | 5.66e-04 | 4 | 289 | 2 | 162900 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 5.66e-04 | 4 | 289 | 2 | C4011754 | |
| Disease | Juvenile neuronal ceroid lipofuscinosis | 5.66e-04 | 4 | 289 | 2 | cv:CN293564 | |
| Disease | Carcinoma in situ of stomach | 5.71e-04 | 17 | 289 | 3 | C0154060 | |
| Disease | Benign neoplasm of stomach | 5.71e-04 | 17 | 289 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.71e-04 | 17 | 289 | 3 | C0496905 | |
| Disease | ciliopathy (implicated_via_orthology) | 6.24e-04 | 40 | 289 | 4 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of endometrium | 6.80e-04 | 18 | 289 | 3 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 6.80e-04 | 18 | 289 | 3 | C0346191 | |
| Disease | Congenital small ears | 6.86e-04 | 41 | 289 | 4 | C0152423 | |
| Disease | Liver Cirrhosis, Experimental | PSMB9 ACOX2 ANGPTL3 NID1 ALB BICD2 SELENOP HYKK RBL2 CHSY1 XPNPEP2 GSTA2 GSTA3 IGF2R CCNB2 GPR68 PYCARD CD53 | 6.88e-04 | 774 | 289 | 18 | C0023893 |
| Disease | Ciliopathies | 7.66e-04 | 110 | 289 | 6 | C4277690 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 9.38e-04 | 5 | 289 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 9.38e-04 | 5 | 289 | 2 | C0334082 | |
| Disease | scoliosis (implicated_via_orthology) | 9.38e-04 | 5 | 289 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Infantile neuronal ceroid lipofuscinosis | 9.38e-04 | 5 | 289 | 2 | C0268281 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.02e-03 | 206 | 289 | 8 | C0152013 | |
| Disease | Lung diseases | 1.03e-03 | 78 | 289 | 5 | C0024115 | |
| Disease | Polydactyly | 1.06e-03 | 117 | 289 | 6 | C0152427 | |
| Disease | Stomach Carcinoma | 1.09e-03 | 21 | 289 | 3 | C0699791 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.15e-03 | 47 | 289 | 4 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 1.25e-03 | 22 | 289 | 3 | DOID:2671 (is_implicated_in) | |
| Disease | Leber Congenital Amaurosis | 1.25e-03 | 22 | 289 | 3 | C0339527 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.25e-03 | 22 | 289 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | Angioedema | 1.40e-03 | 6 | 289 | 2 | C0002994 | |
| Disease | Respiratory Tract Diseases | 1.40e-03 | 6 | 289 | 2 | C0035242 | |
| Disease | recombination measurement | 1.40e-03 | 6 | 289 | 2 | EFO_0005919 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 1.62e-03 | 24 | 289 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | Noonan Syndrome | 1.62e-03 | 24 | 289 | 3 | C0028326 | |
| Disease | Hypotension | 1.81e-03 | 53 | 289 | 4 | C0020649 | |
| Disease | Craniosynostosis syndrome | 1.94e-03 | 7 | 289 | 2 | cv:C0010278 | |
| Disease | Arima syndrome | 1.94e-03 | 7 | 289 | 2 | C1855675 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.94e-03 | 7 | 289 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Sacral agenesis | 1.94e-03 | 7 | 289 | 2 | C0344490 | |
| Disease | Renal dysplasia and retinal aplasia | 1.94e-03 | 7 | 289 | 2 | cv:C0403553 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 2.05e-03 | 26 | 289 | 3 | EFO_0009944 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.08e-03 | 55 | 289 | 4 | C0079744 | |
| Disease | Colorectal cancer | 2.29e-03 | 27 | 289 | 3 | cv:C0346629 | |
| Disease | Neoplasm of the large intestine | 2.29e-03 | 27 | 289 | 3 | cv:C0009404 | |
| Disease | COLORECTAL CANCER | 2.29e-03 | 27 | 289 | 3 | 114500 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.29e-03 | 27 | 289 | 3 | C1112155 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.54e-03 | 139 | 289 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Urologic Neoplasms | 2.57e-03 | 8 | 289 | 2 | C0042076 | |
| Disease | neutropenia (is_implicated_in) | 2.57e-03 | 8 | 289 | 2 | DOID:1227 (is_implicated_in) | |
| Disease | Cancer of Urinary Tract | 2.57e-03 | 8 | 289 | 2 | C0751571 | |
| Disease | endometrial cancer (implicated_via_orthology) | 2.57e-03 | 8 | 289 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 2.58e-03 | 96 | 289 | 5 | C1319315 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 2.81e-03 | 29 | 289 | 3 | C1274933 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.81e-03 | 29 | 289 | 3 | C1333990 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 2.81e-03 | 29 | 289 | 3 | C0496920 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 2.81e-03 | 29 | 289 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 2.81e-03 | 29 | 289 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 2.81e-03 | 29 | 289 | 3 | C0014518 | |
| Disease | Adenoid Cystic Carcinoma | 3.07e-03 | 100 | 289 | 5 | C0010606 | |
| Disease | Ovarian Carcinoma | 3.10e-03 | 30 | 289 | 3 | C0029925 | |
| Disease | Stevens-Johnson Syndrome | 3.10e-03 | 30 | 289 | 3 | C0038325 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 3.22e-03 | 62 | 289 | 4 | EFO_0004616, EFO_1000786 | |
| Disease | Hepatocellular carcinoma | 3.29e-03 | 9 | 289 | 2 | cv:C2239176 | |
| Disease | Neuronal ceroid lipofuscinosis | 3.29e-03 | 9 | 289 | 2 | cv:C0027877 | |
| Disease | HEPATOCELLULAR CARCINOMA | 3.29e-03 | 9 | 289 | 2 | 114550 | |
| Disease | breast cancer (is_implicated_in) | 3.70e-03 | 150 | 289 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Meckel-Gruber syndrome | 4.08e-03 | 10 | 289 | 2 | cv:C0265215 | |
| Disease | Hermanski-Pudlak Syndrome | 4.08e-03 | 10 | 289 | 2 | C0079504 | |
| Disease | Hermansky-Pudlak syndrome | 4.08e-03 | 10 | 289 | 2 | cv:C0079504 | |
| Disease | Non-Small Cell Lung Carcinoma | 4.48e-03 | 156 | 289 | 6 | C0007131 | |
| Disease | colon cancer (implicated_via_orthology) | 4.96e-03 | 11 | 289 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | microfibrillar-associated protein 2 measurement | 4.96e-03 | 11 | 289 | 2 | EFO_0801801 | |
| Disease | Endometrioma | 5.21e-03 | 161 | 289 | 6 | C0269102 | |
| Disease | Endometriosis | 5.21e-03 | 161 | 289 | 6 | C0014175 | |
| Disease | colon cancer (is_implicated_in) | 5.23e-03 | 36 | 289 | 3 | DOID:219 (is_implicated_in) | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 5.23e-03 | 36 | 289 | 3 | DOID:3907 (is_marker_for) | |
| Disease | estrogen-receptor negative breast cancer | 5.24e-03 | 71 | 289 | 4 | EFO_1000650 | |
| Disease | Endometrial Carcinoma | 5.50e-03 | 72 | 289 | 4 | C0476089 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 5.65e-03 | 37 | 289 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | ATR MYO9B KAT2A NEB RRM1 TRRAP LONP1 NOD1 PTPRJ PIK3CA CC2D2A ABCC10 XPO1 GTF3C1 LSM14B MYO16 | 5.79e-03 | 799 | 289 | 16 | EFO_0010701 |
| Disease | Prenatal Exposure Delayed Effects | 5.91e-03 | 12 | 289 | 2 | C0033054 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 5.91e-03 | 12 | 289 | 2 | DOID:0112182 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQYYLSKIEELQLIV | 21 | P62195 | |
| SIQRAALVVLENYYK | 271 | Q8TAA9 | |
| YNLKIIYNALIENEL | 231 | Q9UKU6 | |
| NSIFYVLLAVYLDQV | 406 | Q8WWZ7 | |
| LYGKVLTDEQYQAVR | 136 | Q9ULZ3 | |
| ATEFLKQILNGVYYL | 116 | P53355 | |
| TVLYLQVARFLVKSY | 441 | Q99424 | |
| LTITDFINILHRYYK | 86 | P54619 | |
| KSYEAYVLNIVRFLE | 96 | P05026 | |
| ILLFVYEQKLNEYVA | 101 | P19397 | |
| LVNYVTKELRAEIQY | 136 | Q9NSK7 | |
| QITGYKQLYLDVESV | 101 | Q8IZ81 | |
| IRAIYQVYNALQEKV | 206 | Q15018 | |
| QLGEYKFQNALLVRY | 421 | P02768 | |
| EQYYVRKVLELQTEL | 111 | Q8TD16 | |
| LLTKYAEQLLQEYVQ | 36 | Q16619 | |
| YVLEYQVQGLLADKT | 31 | O43310 | |
| EEYQLLLQVTYRDSK | 46 | Q5T601 | |
| AVTEDVNIYQKYIAR | 456 | Q86V15 | |
| ADYVTAAGKIIYNLR | 161 | Q9BWW8 | |
| LDVILYYIVSKQFQA | 281 | Q14330 | |
| IIYVLQYLEKAGLLT | 981 | A8K2U0 | |
| LNIYLDELIKNTQTY | 1401 | A8K2U0 | |
| YVFIASIYLLGEKLN | 201 | Q96IZ2 | |
| VYDQQREVYVKGLLA | 186 | Q53EZ4 | |
| LYYNGVDIIDLAKQQ | 336 | Q9C0A0 | |
| VQLQTLLQSKYVEYF | 1501 | Q96DT5 | |
| LLQSKYVEYFIEQVL | 1506 | Q96DT5 | |
| KVGDLLQAVLQYYEV | 1866 | Q9UKA4 | |
| LVIAQALSEYNRQYK | 246 | Q5T2E6 | |
| ALILQRTFLQASYYV | 361 | O60706 | |
| YSIVKQSNYVLRIEL | 321 | Q9Y5C1 | |
| SYKQLRATFQAYQIL | 201 | P27216 | |
| YRESIFELLQQITYL | 131 | Q9BTT0 | |
| YAIEAKNRVIFDLIY | 236 | A6QL64 | |
| VSKRYGTQSLINLIY | 916 | Q6Q4G3 | |
| ISLKATYIQNYRLRG | 336 | Q01459 | |
| GLYLYKNILAILSVQ | 221 | Q7L5Y6 | |
| VLRYGVQKRIYCNAL | 786 | Q8IYB7 | |
| RDYFIATCKQGYQLI | 331 | P00736 | |
| YYLRQEVIGDQADKI | 1746 | Q9P2D1 | |
| YQLKVQLASADYFVL | 181 | Q9NRD1 | |
| IRYAVQVLLNVSKYE | 3316 | Q8IZT6 | |
| DYILAQVQAVRLLSY | 201 | Q5T9G4 | |
| NRYTEKQIGYLFISV | 86 | O94973 | |
| KLVYVYLVRYAEEQQ | 96 | O00203 | |
| KLVYVYLVRYAEEQQ | 91 | Q13367 | |
| VKVYTINLESQYLLI | 36 | Q5RL73 | |
| VSVKELDLFLAYYVQ | 171 | O00712 | |
| RFINVKKGQQIYVYS | 56 | Q9NRC9 | |
| VQTRAILNYIASKYN | 66 | P08263 | |
| VQTRAILNYIASKYN | 66 | Q7RTV2 | |
| YYVTRKLFVADLQRV | 786 | Q92830 | |
| LQAEVYGARLAAKYL | 196 | Q9HD26 | |
| DRITRYQGVNLYVKN | 286 | P11940 | |
| DRYKAIINPLLYTVN | 121 | Q8NH69 | |
| ISRLYAQYFQGDLKL | 361 | Q15118 | |
| YTLRSVNDLYIQKQF | 216 | P05546 | |
| RLVDVLKNYEIIFYL | 401 | O95907 | |
| ERGDLIQFYNNIYIK | 1001 | Q08999 | |
| YLTYNANAFRILLKE | 1281 | Q7Z5J8 | |
| VQRLYKAILGDYSQQ | 456 | O43747 | |
| IETYKVNVSERLVQY | 86 | P21397 | |
| KLIYRQYAALFIVVG | 56 | Q9Y587 | |
| YEVYKVTLQARGAVL | 346 | Q5T3U5 | |
| ERISRYQGVNLYIKN | 286 | Q13310 | |
| YQGVNLYIKNLDDTI | 291 | Q13310 | |
| YIQGVLLALYQRLKS | 386 | M0R2J8 | |
| YNNVLPYDISRVKLS | 1071 | Q12913 | |
| KSVGNYYRLVTNAAL | 396 | Q9Y5G7 | |
| IEIVLLYRTYQSKDQ | 386 | O95256 | |
| LTKEYQALQRAYALL | 481 | Q96AA8 | |
| VNLLLYVVDLAYSQR | 286 | A6NDP7 | |
| VTKDLVREGYLEYQQ | 246 | A8MXT2 | |
| NIVLTDYEYVILNIL | 121 | O60524 | |
| ALQLKYLYLNSNRVT | 166 | Q6UXM1 | |
| QQLTGARIYTYLLEK | 566 | Q9Y6X6 | |
| LIDGKYYQADQLVQR | 451 | Q03001 | |
| IVKIYRAESYAGLQE | 246 | Q17RB8 | |
| LISKAQIRYEGILYT | 16 | Q9BX40 | |
| QSKYGSLYRRDNVIL | 176 | Q9NR71 | |
| YTVELEAFAIYKVLQ | 726 | Q6ZU64 | |
| KDRLVNQPLAVYSYL | 856 | P54707 | |
| LYINYSEEIKSNIQR | 446 | Q9H9K5 | |
| VSYLLQEIYGIENKN | 246 | O60291 | |
| KEQELTYELQQGYRI | 71 | Q5HYC2 | |
| YYNSRNVGLILTLVL | 46 | Q2LD37 | |
| LGNSQREYEKQVVLY | 26 | Q658Y4 | |
| LAVKKYFQRITLYLT | 141 | P01568 | |
| IVYGLLNQNFRREYK | 306 | P49286 | |
| TIEAYKREIYQLNSL | 336 | Q5BJE1 | |
| RKRVIATYQNIAVYE | 286 | Q9NRD8 | |
| RKLTLSQIYQYVAGN | 121 | Q6ZQN5 | |
| VQTRAILNYIASKYN | 66 | P09210 | |
| VQTRAILNYIASKYN | 66 | Q16772 | |
| VYLGAVNALYQLDAK | 46 | O15031 | |
| YRLFAVYTLQTLEKL | 116 | Q1X8D7 | |
| NYYKLVIAGALNREQ | 396 | Q9Y5G3 | |
| RVYSDYLQTILKELQ | 96 | Q96HM7 | |
| IILQTYRAIANYEKT | 156 | P14598 | |
| LYNQEEKILRYALSN | 641 | P14543 | |
| IRQYNKISYVLVEFE | 551 | Q96JB1 | |
| KDYYQLLVTRSQVIF | 21 | Q8NEA4 | |
| AEKRLTLSGIYQYII | 71 | P58012 | |
| QRFSITAQLLVLYYI | 641 | Q9H0H0 | |
| SNVRIDKVDGIYLLY | 36 | Q99712 | |
| AVLYQERENGKLYQT | 206 | O60928 | |
| LYCVVIIQKNYRAFL | 766 | Q9HD67 | |
| KIVTYLGLYNNQITD | 756 | Q9Y239 | |
| GRFALIIYENILKYV | 131 | P52848 | |
| QRALYLAVYDLSKGQ | 1411 | Q5S007 | |
| YVAQEKLAIAERYLV | 661 | P36776 | |
| DVAYQKLSQLIREYL | 586 | Q96M69 | |
| RVQRKLEQVYYFLEQ | 461 | O15553 | |
| DYYIERLGSAIQKII | 1131 | Q07864 | |
| ERGKVYVYELRQNLF | 511 | Q9UKX5 | |
| VRKYFQLDVTLAQLY | 96 | O15527 | |
| VLAAANVVRNISYKY | 96 | P28065 | |
| LLDYELVNSYKINIQ | 306 | Q9UN67 | |
| ISYVLATNIYLRKQL | 516 | Q6NUT2 | |
| QFYITLQATPYLDRK | 256 | Q8IXY8 | |
| YIALYQSQRAVLKER | 846 | Q08379 | |
| LYRIASFLQLKNYVQ | 61 | P42694 | |
| YITIENLGASYRKLI | 346 | Q86Y13 | |
| LVQYAYTGVLQLKED | 236 | Q9C0H6 | |
| VRLTYKNRLYFSVQA | 1211 | Q8IVE3 | |
| ATYVNVNIRDIDKIY | 341 | P42336 | |
| VQVLKYEQYLDNLLV | 636 | P42336 | |
| PIILQTYRAIANYEK | 156 | A6NI72 | |
| DRITRYQVVNLYVKN | 286 | Q9H361 | |
| YIGIIDILQSYRFVK | 346 | A2A3N6 | |
| VPARSLYAYIQKLAQ | 1656 | Q13332 | |
| GLKDSQFSIRYQYLL | 961 | O00750 | |
| NLRAYSSRYKVQDII | 121 | Q7RTY9 | |
| LKQRYDSVINRLYTG | 1326 | O94913 | |
| IYQSKVRELISDNQY | 31 | P25205 | |
| YRNVKRNYNALITIG | 51 | Q9NQV7 | |
| AYSKVVQERLVQAEY | 171 | P50897 | |
| AEEYVQQKRELLTLY | 516 | Q3KR16 | |
| VGNNLLVLVLYYKFQ | 56 | Q9H1Y3 | |
| QYQKRFIELYRQISA | 496 | Q567U6 | |
| YESALQVRKVYVRNI | 361 | Q13535 | |
| EGANLEYLKNIIYRF | 716 | Q96CN9 | |
| LVIKEATAYDRGNYI | 2491 | Q6WRI0 | |
| KYLYALGQNRNREIV | 186 | A2RU49 | |
| RIANTYNLTEVDKYV | 201 | Q9P2N7 | |
| VLAAKLAQLYDQYLA | 426 | Q9P2K1 | |
| LAYVTYQDIRKISGL | 296 | O00716 | |
| YSLEIGSLAAVYRQK | 441 | Q96AV8 | |
| KDIYQYLRQLEVLQS | 136 | O95067 | |
| DIYQTLRGYAQKLVS | 111 | Q9P109 | |
| EIKYLNNIISEYERT | 1371 | O15078 | |
| LQAATKYRVLVSAIY | 801 | Q9P218 | |
| KGISQAARYVYQRLI | 406 | Q8NCG7 | |
| IQIKNISRAILDEYY | 516 | Q5T0N1 | |
| NYILQVLVGRESEYK | 1086 | Q53EP0 | |
| VGREFVRQYYTLLNK | 11 | Q9UN86 | |
| EVRQRYINLFVEKYL | 41 | P0C843 | |
| EDLNNKYLYIAVTVI | 316 | P01031 | |
| LPFIQRVYNVSQKLY | 191 | Q5TA50 | |
| IIYNQGFEIVLNDYK | 86 | P53634 | |
| VETLRAAIKYINYLQ | 131 | Q9NQ33 | |
| KYQIIYANAELRVLA | 391 | Q9UQ52 | |
| NESEVLGYKILYRQN | 931 | Q9UQ52 | |
| ILRYTNYQVALANKG | 361 | Q674R7 | |
| ISIYQIIKEYTNRDA | 216 | P22003 | |
| GKYYETALQAALTVR | 381 | Q5VSG8 | |
| IQELNAIYKEYESIL | 511 | O15068 | |
| EAIATRQNEKYYILR | 531 | P33908 | |
| VEAVAVRQAEKYYIL | 516 | O60476 | |
| LVERYLIEIAKNYNV | 161 | P53990 | |
| DLKYIYNQLRTITVR | 261 | Q9NYC9 | |
| DKRLTLSQIYQYVAD | 141 | Q12951 | |
| DLFQRGYYQIRVTLK | 21 | Q49AJ0 | |
| LYVLVEYAAKGNLRE | 551 | P22607 | |
| VYIYDADRGLSVLQK | 146 | P42261 | |
| IQLARRYLQKGYTTL | 586 | Q92902 | |
| SLAKINIVYQELNYR | 661 | P51172 | |
| LNIYYAYIQATLTLK | 181 | P0C7U9 | |
| IVAQELLYRYKQNRS | 151 | Q5EB52 | |
| DLLLVRQYRVEVYKN | 91 | P43246 | |
| NAYAVLYDIILKNFE | 221 | Q06323 | |
| HSRALYYKLAVEQLQ | 41 | Q9GZY4 | |
| NVENKYSLYVGLVLA | 61 | Q6NVV3 | |
| ILYYQDHSTKFIILR | 281 | Q6ZNG9 | |
| YQVILYVLTRLQAEE | 2461 | Q12923 | |
| LAQQQAVIRGFTYYK | 281 | Q68BL7 | |
| GLAIKNDNLVYVYNL | 896 | Q16363 | |
| LLDYELVNSYKINIQ | 306 | Q9Y5E1 | |
| YVNTYGRIIKDVVLQ | 1236 | Q8N4C8 | |
| LSLYFGYLQIKARNE | 41 | Q15743 | |
| VINYTEQLLRGLSYL | 1346 | Q13233 | |
| IYRTYSIAEKLGINA | 101 | Q6KF10 | |
| LRYVDQVLQLVYKDG | 1581 | P11717 | |
| SESKARELYLQVIQY | 296 | Q9BRS2 | |
| QARLVVATQNYYKLV | 386 | Q8N2Y8 | |
| YEKVVQRILYLQVLD | 211 | O43581 | |
| SYQITEKQLQVLLAY | 2196 | O75691 | |
| QYAELGKLYSVVSQL | 2221 | Q93008 | |
| KYYRQTLLFGALQDA | 526 | Q68CQ4 | |
| GVATKLLYQLYIALQ | 91 | Q9C093 | |
| AIAYILQGVLKALDY | 171 | Q7RTN6 | |
| YVNLRLEAIRAEYQK | 171 | P0CI25 | |
| NVIRTKQYLYVADLA | 421 | Q8NBJ9 | |
| YSLVQDYVKGQLLIL | 591 | A2VEC9 | |
| RGVQVNYDLALKYFQ | 461 | Q9UBV2 | |
| KLGVVYFLQYIRETN | 711 | Q9UBV2 | |
| IQLAEKTYNYIYIEI | 421 | Q68DH5 | |
| VYQLARQYSLRIKSN | 926 | A1L390 | |
| CRKYNVTVIQYIGEL | 301 | O14975 | |
| YINQEVVRLYLAVLS | 241 | Q96ME1 | |
| LVIYTNGYIIFKRNT | 421 | Q8NEA9 | |
| RVKSARAIQITYYLQ | 166 | Q6ZW05 | |
| LEYLQADYNVIKRIE | 151 | O94933 | |
| KYNLINEYFLVGVTE | 241 | Q7LGA3 | |
| LRVVIVKTYLNENGY | 621 | Q9H2Y9 | |
| LQSLQYLYLEYNVIK | 446 | Q9H156 | |
| IYAIRQSISKALVAY | 81 | P62249 | |
| AALISYYVKRQPAIQ | 666 | O75182 | |
| AGKIYYILRQSELVD | 1076 | Q8TE82 | |
| YILRQSELVDLYIQV | 1081 | Q8TE82 | |
| ALLKYVEFIQNSVYA | 281 | O15457 | |
| LFYRVNYIGTKNVIE | 116 | Q15738 | |
| KVVLNTNGLYYNLEL | 481 | Q75T13 | |
| QSIALYFEGEKRYLQ | 1011 | Q8NEZ3 | |
| NYFYRVSLIKQSAQL | 201 | Q96A49 | |
| ENLYQLTLRAAGKTY | 386 | Q9NY46 | |
| ELASAVRNAKYLVVY | 91 | Q9NRC8 | |
| YISADILKLVGNYVR | 136 | Q07889 | |
| LLSTYLERYKVQNNL | 1291 | Q12769 | |
| QLQEYEAIYLAKLTI | 166 | Q8WUJ0 | |
| YIVVNHQGISSRLKY | 86 | P49908 | |
| DVELYGQYLERLKQF | 266 | Q5VST6 | |
| LLLQRTFLQASYYVA | 366 | Q09428 | |
| EAFTEQLYRYVTKLL | 401 | Q9H553 | |
| ENSYGKINILLQTYI | 1051 | Q8N3C0 | |
| TKVANVELYYRAIQF | 1396 | Q00610 | |
| IIDFKEIQYGYRRVN | 426 | Q86X52 | |
| LIDFKEIQYGYRRVN | 516 | Q70JA7 | |
| LLEAYVKGQQELLYV | 1221 | A5YKK6 | |
| LYKFVGRINIYSNSL | 221 | Q8NB49 | |
| LYQQVILKGDFNYLE | 2351 | Q96JI7 | |
| LQVLTYLQAYKEAFA | 111 | Q9UNS1 | |
| SVLSQQAYVLFYIQK | 361 | A6NCW0 | |
| KYYGLQILENVIKTR | 76 | O14980 | |
| FILRQNTLVYYKLEG | 26 | Q9NYT0 | |
| LGYQISKSYIILQLE | 46 | Q6ZN79 | |
| YRDVILENYSNLVSL | 31 | Q9Y2G7 | |
| YLISLKGYFSQEVNI | 101 | P23510 | |
| AVTKNLGLYYDNRIR | 486 | Q05086 | |
| SVLSQQAYVLFYIQK | 361 | A6NCW7 | |
| YNISKQVLDQYLTLL | 301 | Q9BUI4 | |
| LVLYNEIEYAQAAVK | 556 | Q96T58 | |
| LLNKQIFETIYYGAL | 526 | P23921 | |
| NYALTLLVIYFLQTR | 431 | Q9H6E5 | |
| YVSLRIEAIRAEYQK | 171 | Q9BSJ1 | |
| QKSRQLYAIIAEYGS | 76 | Q8TAQ9 | |
| YVNLRLEAIRAEYQK | 171 | P0CI26 | |
| SVLSQQAYVLFYIQK | 361 | D6R9N7 | |
| NDYYARLFGIKSVIQ | 301 | Q9H5I5 | |
| GEYRVKVYQLLVNEQ | 1121 | Q96K76 | |
| SVLSQQAYVLFYIQK | 361 | A8MUK1 | |
| VYAQLLTGRKYQINQ | 796 | Q8IZH2 | |
| SVLSQQAYVLFYIQK | 361 | D6R901 | |
| SVLSQQAYVLFYIQK | 361 | C9JLJ4 | |
| KVLGQSVFLNDIYYA | 1771 | P21359 | |
| VLVIYENLLKYVNLD | 136 | P52849 | |
| YLLQLVQVLKYESYL | 611 | O00329 | |
| TLIKAVYTLYQQRGL | 501 | Q9NXF1 | |
| GLQLIYYSFDVKDIN | 61 | A0A075B6N3 | |
| SVLSQQAYVLFYIQK | 361 | D6RCP7 | |
| AQRYLAQKYCILVLG | 196 | Q96LQ0 | |
| LTYQAEGSRQALKVY | 1366 | Q70Z35 | |
| SVLSQQAYVLFYIQK | 361 | Q7RTZ2 | |
| VLASLAYQRYKAGVD | 161 | O43760 | |
| RKVSVYLLTGLELYQ | 896 | Q96RU2 | |
| ELLVEYVRKQIQYLD | 246 | Q9NVA1 | |
| LGYQISKSYIILQLE | 46 | A8MWA4 | |
| LGYQISKSYIILQLE | 46 | A8MUZ8 | |
| QVALNFIISYLYNKL | 6 | P50616 | |
| SVLSQQAYVLFYIQK | 361 | C9JPN9 | |
| LGYQISKSYIILQLE | 46 | P0CI00 | |
| LGYQISKSYIILQLE | 46 | P0CH99 | |
| SVLSQQAYVLFYIQK | 361 | Q0WX57 | |
| LKAAIEYQLRNYEVA | 256 | Q86WT1 | |
| SVLSQQAYVLFYIQK | 361 | P0C7H9 | |
| SVLSQQAYVLFYIQK | 361 | P0C7I0 | |
| LQYLNRYYQTIREKV | 611 | O43895 | |
| YVNLRLEAIRAEYQK | 171 | A6NDI0 | |
| SVLSQQAYVLFYIQK | 361 | Q6QN14 | |
| ITAIYADYARSLKNL | 1176 | Q9BZH6 | |
| SALINAAIRKLNYTY | 591 | O75127 | |
| LYKRRYIFSVVENLQ | 956 | Q12789 | |
| SVLSQQAYVLFYIQK | 361 | D6RA61 | |
| SVLSQQAYVLFYIQK | 361 | C9J2P7 | |
| SVLSQQAYVLFYIQK | 361 | D6RBQ6 | |
| LAARYIDFLYQVLQS | 151 | Q15672 | |
| KTLSFLAYIIRIYQE | 286 | Q9Y4A5 | |
| ILYRDVILENYSNLV | 31 | Q8NDW4 | |
| SVLSQQAYVLFYIQK | 361 | Q6R6M4 | |
| LISKYGFQEQLLYSV | 206 | O94874 | |
| SVLSQQAYVLFYIQK | 361 | D6RJB6 | |
| SVLSQQAYVLFYIQK | 361 | C9JJH3 | |
| SVLSQQAYVLFYIQK | 361 | C9JVI0 | |
| YGKYLTLENVADLVR | 76 | O14773 | |
| TLKLAARYIDFLYQV | 106 | Q8WVJ9 | |
| QVFINYKERLVIYGQ | 266 | Q9UKW4 | |
| IFREYLTYLNQLGTL | 246 | P23276 | |
| LYQTKYQELQITAGR | 356 | Q7Z794 | |
| LQQKIYTYAGSILVA | 171 | Q13459 | |
| RGQKLQSQYLYVELA | 5186 | P20929 |